Related Experiment Video
Updated: Apr 26, 2026

05:05
Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
12.0K
[Challenges in inpatient ophthalmology for elderly patients]
1Klinik für Augenheilkunde, Klinikum Frankfurt/Oder GmbH, Müllroser Chaussee 7, 15236, Frankfurt/Oder, Deutschland, mareike.pietzsch@gmx.de.
Summary
Elderly patients over 80 years old, especially those over 90, present with more ocular problems and comorbidities. This highlights challenges in clinical care for aging populations.
Area of Science:
- Ophthalmology
- Geriatrics
- Internal Medicine
Context:
- Demographic shifts indicate a growing elderly patient population.
- Ophthalmology faces increasing demand from aging individuals.
- Clinical settings must adapt to the needs of older patients.
Purpose:
- To assess ocular problems in elderly inpatients (60+).
- Focus on very old patients (80+ and 90+).
- Investigate age-related ocular conditions and comorbidities.
Summary:
- Inpatients aged 80+ and 90+ show higher rates of ocular issues and comorbidities.
- Mean patient age in ophthalmology is 69, highest among disciplines.
- Increased diagnoses, reduced mobility, dementia, and visual disorders noted in the oldest groups.
Impact:
- Old and very old patients present complex treatment needs.
- Increased comorbidity requires specialized medical and nursing care.
- Clinical settings face challenges in managing aging patient populations.
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
849
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
849
Photoreceptors and Visual Pathways
8.3K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
8.3K
Drug Dosing: Geriatric Patients
392
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
392
Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Ophthalmic Drug Delivery Systems
279
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
279
Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K

